Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

CD8+ T cells expand stem and progenitor cells in favorable but not adverse risk acute myeloid leukemia.

Radpour R, Riether C, Simillion C, Höpner S, Bruggmann R, Ochsenbein AF.

Leukemia. 2019 Oct;33(10):2379-2392. doi: 10.1038/s41375-019-0441-9. Epub 2019 Mar 15.

PMID:
30877275
2.

Single-cell analysis of tumors: Creating new value for molecular biomarker discovery of cancer stem cells and tumor-infiltrating immune cells.

Radpour R, Forouharkhou F.

World J Stem Cells. 2018 Nov 26;10(11):160-171. doi: 10.4252/wjsc.v10.i11.160. Review.

3.

T-cell-Secreted TNFα Induces Emergency Myelopoiesis and Myeloid-Derived Suppressor Cell Differentiation in Cancer.

Al Sayed MF, Amrein MA, Bührer ED, Huguenin AL, Radpour R, Riether C, Ochsenbein AF.

Cancer Res. 2019 Jan 15;79(2):346-359. doi: 10.1158/0008-5472.CAN-17-3026. Epub 2018 Nov 2.

PMID:
30389698
4.

TIRAP p.R81C is a novel lymphoma risk variant which enhances cell proliferation via NF-κB mediated signaling in B-cells.

Burkhard R, Keller I, Arambasic M, Juskevicius D, Tzankov A, Lundberg P, Bruggmann R, Dirnhofer S, Radpour R, Novak U.

Haematologica. 2019 Apr;104(4):766-777. doi: 10.3324/haematol.2018.201590. Epub 2018 Oct 31.

5.

Macroscale multimodal imaging reveals ancient painting production technology and the vogue in Greco-Roman Egypt.

Delaney JK, Dooley KA, Radpour R, Kakoulli I.

Sci Rep. 2017 Nov 14;7(1):15509. doi: 10.1038/s41598-017-15743-5.

6.

Tracing and targeting cancer stem cells: New venture for personalized molecular cancer therapy.

Radpour R.

World J Stem Cells. 2017 Oct 26;9(10):169-178. doi: 10.4252/wjsc.v9.i10.169. Review.

7.

Hydrogen sulfide attenuates calcification of vascular smooth muscle cells via KEAP1/NRF2/NQO1 activation.

Aghagolzadeh P, Radpour R, Bachtler M, van Goor H, Smith ER, Lister A, Odermatt A, Feelisch M, Pasch A.

Atherosclerosis. 2017 Oct;265:78-86. doi: 10.1016/j.atherosclerosis.2017.08.012. Epub 2017 Aug 19.

PMID:
28865326
8.

CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies.

Al Sayed MF, Ruckstuhl CA, Hilmenyuk T, Claus C, Bourquin JP, Bornhauser BC, Radpour R, Riether C, Ochsenbein AF.

Blood. 2017 Jul 20;130(3):297-309. doi: 10.1182/blood-2016-12-756585. Epub 2017 May 11.

PMID:
28495792
9.

The Multi-kinase Inhibitor Debio 0617B Reduces Maintenance and Self-renewal of Primary Human AML CD34+ Stem/Progenitor Cells.

Murone M, Radpour R, Attinger A, Chessex AV, Huguenin AL, Schürch CM, Banz Y, Sengupta S, Aguet M, Rigotti S, Bachhav Y, Massière F, Ramachandra M, McAllister A, Riether C.

Mol Cancer Ther. 2017 Aug;16(8):1497-1510. doi: 10.1158/1535-7163.MCT-16-0889. Epub 2017 May 3.

10.

CD70/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemia.

Riether C, Schürch CM, Bührer ED, Hinterbrandner M, Huguenin AL, Hoepner S, Zlobec I, Pabst T, Radpour R, Ochsenbein AF.

J Exp Med. 2017 Feb;214(2):359-380. doi: 10.1084/jem.20152008. Epub 2016 Dec 28.

11.

New trends in molecular and cellular biomarker discovery for colorectal cancer.

Aghagolzadeh P, Radpour R.

World J Gastroenterol. 2016 Jul 7;22(25):5678-93. doi: 10.3748/wjg.v22.i25.5678. Review.

12.

Calcification of vascular smooth muscle cells is induced by secondary calciprotein particles and enhanced by tumor necrosis factor-α.

Aghagolzadeh P, Bachtler M, Bijarnia R, Jackson C, Smith ER, Odermatt A, Radpour R, Pasch A.

Atherosclerosis. 2016 Aug;251:404-414. doi: 10.1016/j.atherosclerosis.2016.05.044. Epub 2016 May 27.

PMID:
27289275
13.

Tyrosine kinase inhibitor-induced CD70 expression mediates drug resistance in leukemia stem cells by activating Wnt signaling.

Riether C, Schürch CM, Flury C, Hinterbrandner M, Drück L, Huguenin AL, Baerlocher GM, Radpour R, Ochsenbein AF.

Sci Transl Med. 2015 Jul 29;7(298):298ra119. doi: 10.1126/scitranslmed.aab1740.

PMID:
26223302
14.

Endothelial cells translate pathogen signals into G-CSF-driven emergency granulopoiesis.

Boettcher S, Gerosa RC, Radpour R, Bauer J, Ampenberger F, Heikenwalder M, Kopf M, Manz MG.

Blood. 2014 Aug 28;124(9):1393-403. doi: 10.1182/blood-2014-04-570762. Epub 2014 Jul 2.

15.

Telomere shortening: a biological marker of sporadic colorectal cancer with normal expression of p53 and mismatch repair proteins.

Haghighi MM, Aghagolzadeh P, Zadeh SM, Molaei M, Zali MR, Radpour R.

Genet Test Mol Biomarkers. 2014 Apr;18(4):236-44. doi: 10.1089/gtmb.2013.0436. Epub 2014 Feb 4.

PMID:
24495131
16.

Methylation signature of lymph node metastases in breast cancer patients.

Barekati Z, Radpour R, Lu Q, Bitzer J, Zheng H, Toniolo P, Lenner P, Zhong XY.

BMC Cancer. 2012 Jun 13;12:244. doi: 10.1186/1471-2407-12-244.

17.

Effects of amifostine in combination with cyclophosphamide on female reproductive system.

Barekati Z, Golkar-Narenji A, Totonchi M, Radpour R, Gourabi H.

Reprod Sci. 2012 May;19(5):539-46. doi: 10.1177/1933719111426599. Epub 2012 Jan 19.

PMID:
22267539
18.

Integrated epigenetics of human breast cancer: synoptic investigation of targeted genes, microRNAs and proteins upon demethylation treatment.

Radpour R, Barekati Z, Kohler C, Schumacher MM, Grussenmeyer T, Jenoe P, Hartmann N, Moes S, Letzkus M, Bitzer J, Lefkovits I, Staedtler F, Zhong XY.

PLoS One. 2011;6(11):e27355. doi: 10.1371/journal.pone.0027355. Epub 2011 Nov 4.

19.

Cell-free DNA in the circulation as a potential cancer biomarker.

Kohler C, Barekati Z, Radpour R, Zhong XY.

Anticancer Res. 2011 Aug;31(8):2623-8. Review.

PMID:
21778314
20.

Assessing the value of CAN-gene mutations using MALDI-TOF MS.

Kohler C, Tavelin B, Fan AX, Radpour R, Barekati Z, Levi F, Zhong XY, Lenner P, Toniolo P.

J Cancer Res Clin Oncol. 2011 Aug;137(8):1239-44. doi: 10.1007/s00432-011-0990-4. Epub 2011 Jun 21.

PMID:
21691751
21.

Hypermethylation of tumor suppressor genes involved in critical regulatory pathways for developing a blood-based test in breast cancer.

Radpour R, Barekati Z, Kohler C, Lv Q, Bürki N, Diesch C, Bitzer J, Zheng H, Schmid S, Zhong XY.

PLoS One. 2011 Jan 24;6(1):e16080. doi: 10.1371/journal.pone.0016080.

22.

Specificity of methylation assays in cancer research: a guideline for designing primers and probes.

Barekati Z, Radpour R, Kohler C, Zhong XY.

Obstet Gynecol Int. 2010;2010. pii: 870865. doi: 10.1155/2010/870865. Epub 2010 Jul 27.

23.

Proteomics and biomarkers for ovarian cancer diagnosis.

Zhang B, Barekati Z, Kohler C, Radpour R, Asadollahi R, Holzgreve W, Zhong XY.

Ann Clin Lab Sci. 2010 Summer;40(3):218-25. Review.

PMID:
20689132
24.

Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations.

Barekati Z, Radpour R, Kohler C, Zhang B, Toniolo P, Lenner P, Lv Q, Zheng H, Zhong XY.

Hum Mol Genet. 2010 Aug 1;19(15):2936-46. doi: 10.1093/hmg/ddq199. Epub 2010 May 12.

PMID:
20466735
25.

Correlation of telomere length shortening with promoter methylation profile of p16/Rb and p53/p21 pathways in breast cancer.

Radpour R, Barekati Z, Haghighi MM, Kohler C, Asadollahi R, Torbati PM, Holzgreve W, Zhong XY.

Mod Pathol. 2010 May;23(5):763-72. doi: 10.1038/modpathol.2009.195. Epub 2010 Jan 15.

26.

MALDI-TOF mass array analysis of RASSF1A and SERPINB5 methylation patterns in human placenta and plasma.

Bellido ML, Radpour R, Lapaire O, De Bie I, Hösli I, Bitzer J, Hmadcha A, Zhong XY, Holzgreve W.

Biol Reprod. 2010 Apr;82(4):745-50. doi: 10.1095/biolreprod.109.082271. Epub 2010 Jan 14.

PMID:
20075396
27.

Association between MTHFR polymorphism (C677T) with nonfamilial colorectal cancer.

Haghighi MM, Radpour R, Mahmoudi T, Mohebbi SR, Vahedi M, Zali MR.

Oncol Res. 2009;18(2-3):57-63.

PMID:
20066895
28.

Decreased mitochondrial DNA content in blood samples of patients with stage I breast cancer.

Xia P, An HX, Dang CX, Radpour R, Kohler C, Fokas E, Engenhart-Cabillic R, Holzgreve W, Zhong XY.

BMC Cancer. 2009 Dec 21;9:454. doi: 10.1186/1471-2407-9-454.

29.

Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors.

Kohler C, Radpour R, Barekati Z, Asadollahi R, Bitzer J, Wight E, Bürki N, Diesch C, Holzgreve W, Zhong XY.

Mol Cancer. 2009 Nov 17;8:105. doi: 10.1186/1476-4598-8-105.

30.

New trends in molecular biomarker discovery for breast cancer.

Radpour R, Barekati Z, Kohler C, Holzgreve W, Zhong XY.

Genet Test Mol Biomarkers. 2009 Oct;13(5):565-71. doi: 10.1089/gtmb.2009.0060. Review.

PMID:
19814613
31.

Simultaneous isolation of DNA, RNA, and proteins for genetic, epigenetic, transcriptomic, and proteomic analysis.

Radpour R, Sikora M, Grussenmeyer T, Kohler C, Barekati Z, Holzgreve W, Lefkovits I, Zhong XY.

J Proteome Res. 2009 Nov;8(11):5264-74. doi: 10.1021/pr900591w.

PMID:
19780627
32.

A selected pre-amplification strategy for genetic analysis using limited DNA targets.

Xia P, Radpour R, Kohler C, Dang CX, Fan AX, Holzgreve W, Zhong XY.

Clin Chem Lab Med. 2009;47(3):288-93. doi: 10.1515/CCLM.2009.067.

PMID:
19676139
33.

Current understanding of mitochondrial DNA in breast cancer.

Radpour R, Fan AX, Kohler C, Holzgreve W, Zhong XY.

Breast J. 2009 Sep-Oct;15(5):505-9. doi: 10.1111/j.1524-4741.2009.00767.x. Epub 2009 Jul 13. Review.

PMID:
19624415
34.

Methylation profiles of 22 candidate genes in breast cancer using high-throughput MALDI-TOF mass array.

Radpour R, Kohler C, Haghighi MM, Fan AX, Holzgreve W, Zhong XY.

Oncogene. 2009 Aug 20;28(33):2969-78. doi: 10.1038/onc.2009.149. Epub 2009 Jun 8.

PMID:
19503099
35.

Four novel germline mutations in the MLH1 and PMS2 mismatch repair genes in patients with hereditary nonpolyposis colorectal cancer.

Montazer Haghighi M, Radpour R, Aghajani K, Zali N, Molaei M, Zali MR.

Int J Colorectal Dis. 2009 Aug;24(8):885-93. doi: 10.1007/s00384-009-0731-1. Epub 2009 May 29.

PMID:
19479271
36.

Circulating cell-free DNA as a potential biomarker for minimal and mild endometriosis.

Zachariah R, Schmid S, Radpour R, Buerki N, Fan AX, Hahn S, Holzgreve W, Zhong XY.

Reprod Biomed Online. 2009 Mar;18(3):407-11.

PMID:
19298741
37.

Novel cause of hereditary obstructive azoospermia: a T2 allele in the CFTR gene.

Radpour R, Taherzadeh-Fard E, Gourabi H, Aslani S, Vosough Dizaj A, Aslani A.

Reprod Biomed Online. 2009 Mar;18(3):327-32.

PMID:
19298730
38.

Mitochondrial DNA content in paired normal and cancerous breast tissue samples from patients with breast cancer.

Fan AX, Radpour R, Haghighi MM, Kohler C, Xia P, Hahn S, Holzgreve W, Zhong XY.

J Cancer Res Clin Oncol. 2009 Aug;135(8):983-9. doi: 10.1007/s00432-008-0533-9. Epub 2009 Jan 6.

PMID:
19125299
39.

Simultaneous quantitative assessment of circulating cell-free mitochondrial and nuclear DNA by multiplex real-time PCR.

Xia P, Radpour R, Zachariah R, Fan AX, Kohler C, Hahn S, Holzgreve W, Zhong XY.

Genet Mol Biol. 2009 Jan;32(1):20-4. doi: 10.1590/S1415-47572009000100003. Epub 2009 Mar 1.

40.

Identification of a critical novel mutation in the exon 1 of androgen receptor gene in 2 brothers with complete androgen insensitivity syndrome.

Radpour R, Falah M, Aslani A, Zhong XY, Saleki A.

J Androl. 2009 May-Jun;30(3):230-2. doi: 10.2164/jandrol.108.005520. Epub 2008 Nov 20.

41.

High-throughput hacking of the methylation patterns in breast cancer by in vitro transcription and thymidine-specific cleavage mass array on MALDI-TOF silico-chip.

Radpour R, Haghighi MM, Fan AX, Torbati PM, Hahn S, Holzgreve W, Zhong XY.

Mol Cancer Res. 2008 Nov;6(11):1702-9. doi: 10.1158/1541-7786.MCR-08-0262.

42.

Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors.

Zachariah RR, Schmid S, Buerki N, Radpour R, Holzgreve W, Zhong X.

Obstet Gynecol. 2008 Oct;112(4):843-50. doi: 10.1097/AOG.0b013e3181867bc0.

PMID:
18827127
43.

Genetic investigations of CFTR mutations in congenital absence of vas deferens, uterus, and vagina as a cause of infertility.

Radpour R, Gourabi H, Dizaj AV, Holzgreve W, Zhong XY.

J Androl. 2008 Sep-Oct;29(5):506-13. doi: 10.2164/jandrol.108.005074. Epub 2008 Jun 20. Review.

44.

Genes controlling spread of breast cancer to lung "gang of 4".

Eltarhouny SA, Elsawy WH, Radpour R, Hahn S, Holzgreve W, Zhong XY.

Exp Oncol. 2008 Jun;30(2):91-5. Review.

PMID:
18566569
45.

Retraction. Association of long polyglutamine tracts in exon 1 of the androgen receptor gene with idiopathic male infertility.

Radpour R, Zhong X, Tavasoly A, Solati S, Holzgreve W.

J Androl. 2008 May-Jun;29(3):368. doi: 10.2164/jandrol.107.004192. Epub 2008 Feb 7. No abstract available.

46.

Correlation between CFTR gene mutations in Iranian men with congenital absence of the vas deferens and anatomical genital phenotype.

Radpour R, Gourabi H, Gilani MA, Dizaj AV.

J Androl. 2008 Jan-Feb;29(1):35-40. Epub 2007 Aug 1.

47.

Molecular study of (TG)m(T)n polymorphisms in Iranian males with congenital bilateral absence of the vas deferens.

Radpour R, Gourabi H, Gilani MA, Dizaj AV.

J Androl. 2007 Jul-Aug;28(4):541-7. Epub 2007 Feb 21.

48.

Two novel missense and one novel nonsense CFTR mutations in Iranian males with congenital bilateral absence of the vas deferens.

Radpour R, Gourabi H, Gilani MA, Dizaj AV, Rezaee M, Mollamohamadi S.

Mol Hum Reprod. 2006 Nov;12(11):717-21. Epub 2006 Sep 14.

PMID:
16973827
49.
50.

Molecular analysis of the IVS8-T splice variant 5T and M470V exon 10 missense polymorphism in Iranian males with congenital bilateral absence of the vas deferens.

Radpour R, Gilani MA, Gourabi H, Dizaj AV, Mollamohamadi S.

Mol Hum Reprod. 2006 Jul;12(7):469-73. Epub 2006 May 19.

PMID:
16714368

Supplemental Content

Loading ...
Support Center